188 related articles for article (PubMed ID: 18432524)
1. Hydroxycarbamide associated platelet count oscillations in a patient with polycythaemia vera. A case report and review of the literature.
Burthem J; Chaudhry MS
Platelets; 2008 May; 19(3):234-5. PubMed ID: 18432524
[TBL] [Abstract][Full Text] [Related]
2. Cyclic thrombocytopenia and polycythemia vera.
Kojima K; Fujii N; Omoto E; Nose S; Yoneyama M; Sugii Y; Hiramatsu H; Chikatsune M; Sato M; Takata S; Itoshima T; Tanimoto M
Ann Hematol; 2003 Jan; 82(1):61-3. PubMed ID: 12574969
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review.
Steensma DP; Harrison CN; Tefferi A
Leuk Lymphoma; 2001; 42(6):1243-53. PubMed ID: 11911405
[TBL] [Abstract][Full Text] [Related]
4. [Leg ulcers in patient affected by polycythemia vera in treatment with hydroxycarbamide. Case report].
Chiummariello S; Arleo S; Alfano C
G Chir; 2010 Mar; 31(3):120-3. PubMed ID: 20426925
[TBL] [Abstract][Full Text] [Related]
5. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester.
Pata O; Tok CE; Yazici G; Pata C; Oz AU; Aban M; Dilek S
Am J Perinatol; 2004 Apr; 21(3):135-7. PubMed ID: 15085495
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera.
Johansson P; Andréasson B
Clin Lab Haematol; 2006 Aug; 28(4):233-6. PubMed ID: 16898960
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant-resistant thrombophilia in a patient with polycythemia vera: a case report.
Das S; Karachiwala H; Cherian SV; Garcha AS; Jasti S; Gajra A
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):746-8. PubMed ID: 21885951
[TBL] [Abstract][Full Text] [Related]
8. Polycythemia vera in a patient with the human immunodeficiency virus: a case report.
Sassaki MG; Souza CA; Siciliano RF; Leite AG; Padilha SL
Braz J Infect Dis; 2000 Aug; 4(4):204-7. PubMed ID: 11184768
[TBL] [Abstract][Full Text] [Related]
9. Observations with 5-hydroxyurea in the management of polycythaemia vera.
Nagy G; Szegedi J; Petrányi G
Ther Hung; 1972; 20(3):91-5. PubMed ID: 4652145
[No Abstract] [Full Text] [Related]
10. A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process.
Barosi G; Birgegard G; Finazzi G; Griesshammer M; Harrison C; Hasselbalch H; Kiladijan JJ; Lengfelder E; Mesa R; Mc Mullin MF; Passamonti F; Reilly JT; Vannucchi AM; Barbui T
Br J Haematol; 2010 Mar; 148(6):961-3. PubMed ID: 19930182
[No Abstract] [Full Text] [Related]
11. Polycythemia vera in a 12-year-old girl: a case report.
Turker M; Ozer EA; Oniz H; Atabay B; Yaprak I
Pediatr Hematol Oncol; 2002 Jun; 19(4):263-6. PubMed ID: 12051593
[TBL] [Abstract][Full Text] [Related]
12. Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide.
Baird JH; Minniti CP; Lee JM; Tian X; Wu C; Jackson M; Alam S; Taylor JG; Kato GJ
Br J Haematol; 2015 Mar; 168(5):737-46. PubMed ID: 25377027
[TBL] [Abstract][Full Text] [Related]
13. Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
Boivin P
Nouv Rev Fr Hematol (1978); 1993; 35(5):491-8. PubMed ID: 8295823
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera.
Tefferi A; Elliott MA; Kao PC; Yoon S; El-Hemaidi I; Pearson TC
Blood; 2000 Aug; 96(4):1582-4. PubMed ID: 10942409
[TBL] [Abstract][Full Text] [Related]
15. The haematocrit and platelet target in polycythemia vera.
Di Nisio M; Barbui T; Di Gennaro L; Borrelli G; Finazzi G; Landolfi R; Leone G; Marfisi R; Porreca E; Ruggeri M; Rutjes AW; Tognoni G; Vannucchi AM; Marchioli R;
Br J Haematol; 2007 Jan; 136(2):249-59. PubMed ID: 17156406
[TBL] [Abstract][Full Text] [Related]
16. Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera.
Alvarez-Larrán A; Kerguelen A; Hernández-Boluda JC; Pérez-Encinas M; Ferrer-Marín F; Bárez A; Martínez-López J; Cuevas B; Mata MI; García-Gutiérrez V; Aragües P; Montesdeoca S; Burgaleta C; Caballero G; Hernández-Rivas JA; Durán MA; Gómez-Casares MT; Besses C;
Br J Haematol; 2016 Mar; 172(5):786-93. PubMed ID: 26898196
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
Rain JD
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
[TBL] [Abstract][Full Text] [Related]
18. Thrombocytosis, thrombocythaemia and iron deficiency in patients with polycythaemia vera.
Shaw D; Tudhope GR
Acta Haematol; 1979; 62(4):223-8. PubMed ID: 119415
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea and periodicity in myeloproliferative disease.
Bennett M; Grunwald AJ
Eur J Haematol; 2001 May; 66(5):317-23. PubMed ID: 11422411
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF).
Mesa R; Vannucchi AM; Yacoub A; Zachee P; Garg M; Lyons R; Koschmieder S; Rinaldi C; Byrne J; Hasan Y; Passamonti F; Verstovsek S; Hunter D; Jones MM; Zhen H; Habr D; Martino B
Br J Haematol; 2017 Jan; 176(1):76-85. PubMed ID: 27858987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
